Literature DB >> 31097430

Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T.

Y-L Wang1,2, J Yao1,3,4, A Chakhoyan1,3, C Raymond1,3, N Salamon3, L M Liau5,6, P L Nghiemphu7, A Lai7,5, W B Pope3, N Nguyen7, M Ji7, T F Cloughesy7, B M Ellingson8,3,9,10,5,4.   

Abstract

BACKGROUND AND
PURPOSE: Acidification of the tumor microenvironment from abnormal metabolism along with angiogenesis to meet metabolic demands are both hallmarks of malignant brain tumors; however, the interdependency of tumor acidity and vascularity has not been explored. Therefore, our aim was to investigate the association between pH-sensitive amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) and relative cerebral blood volume (CBV) measurements obtained from dynamic susceptibility contrast (DSC) perfusion MRI in patients with gliomas.
MATERIALS AND METHODS: In this retrospective study, 90 patients with histologically confirmed gliomas were scanned between 2015 and 2018 (median age, 50.3 years; male/female ratio = 59:31). pH-weighting was obtained using chemical exchange saturation transfer echo-planar imaging estimation of the magnetization transfer ratio asymmetry at 3 ppm, and CBV was estimated using DSC-MR imaging. The voxelwise correlation and patient-wise median value correlation between the magnetization transfer ratio asymmetry at 3 ppm and CBV within T2-hyperintense lesions and contrast-enhancing lesions were evaluated using the Pearson correlation analysis.
RESULTS: General colocalization of elevated perfusion and high acidity was observed in tumors, with local intratumor heterogeneity. For patient-wise analysis, median CBV and magnetization transfer ratio asymmetry at 3 ppm within T2-hyperintense lesions were significantly correlated (R = 0.3180, P = .002), but not in areas of contrast enhancement (P = .52). The positive correlation in T2-hyperintense lesions remained within high-grade gliomas (R = 0.4128, P = .001) and in isocitrate dehydrogenase wild-type gliomas (R = 0.4300, P = .002), but not in World Health Organization II or in isocitrate dehydrogenase mutant tumors. Both magnetization transfer ratio asymmetry at 3 ppm and the voxelwise correlation between magnetization transfer ratio asymmetry and CBV were higher in high-grade gliomas compared with low-grade gliomas in T2-hyperintense tumors (magnetization transfer ratio asymmetry, P = .02; Pearson correlation, P = .01). The same trend held when comparing isocitrate dehydrogenase wild-type gliomas and isocitrate dehydrogenase mutant gliomas (magnetization transfer ratio asymmetry, P = .04; Pearson correlation, P = .01).
CONCLUSIONS: A positive linear correlation between CBV and acidity in areas of T2-hyperintense, nonenhancing tumor, but not enhancing tumor, was observed across patients. Local heterogeneity was observed within individual tumors.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 31097430      PMCID: PMC6527337          DOI: 10.3174/ajnr.A6063

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

Review 1.  Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Authors:  Benjamin M Ellingson; Martin Bendszus; Jerrold Boxerman; Daniel Barboriak; Bradley J Erickson; Marion Smits; Sarah J Nelson; Elizabeth Gerstner; Brian Alexander; Gregory Goldmacher; Wolfgang Wick; Michael Vogelbaum; Michael Weller; Evanthia Galanis; Jayashree Kalpathy-Cramer; Lalitha Shankar; Paula Jacobs; Whitney B Pope; Dewen Yang; Caroline Chung; Michael V Knopp; Soonme Cha; Martin J van den Bent; Susan Chang; W K Al Yung; Timothy F Cloughesy; Patrick Y Wen; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2015-08-05       Impact factor: 12.300

2.  Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

Authors:  P Wesseling; J A van der Laak; M Link; H L Teepen; D J Ruiter
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

3.  Increased release of tumour cells by collagenase at acid pH: a possible mechanism for metastasis.

Authors:  G A Turner
Journal:  Experientia       Date:  1979-12-15

4.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

5.  In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study.

Authors:  Keven Ferreira da Ponte; David Hassanein Berro; Solène Collet; Jean-Marc Constans; Evelyne Emery; Samuel Valable; Jean-Sébastien Guillamo
Journal:  J Nucl Med       Date:  2017-06-08       Impact factor: 10.057

6.  Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.

Authors:  Anna Tietze; Jakob Blicher; Irene Klaerke Mikkelsen; Leif Østergaard; Megan K Strother; Seth A Smith; Manus J Donahue
Journal:  NMR Biomed       Date:  2013-11-28       Impact factor: 4.044

7.  An evolutionary model of carcinogenesis.

Authors:  Robert A Gatenby; Thomas L Vincent
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 8.  Vascular morphology and angiogenesis in glial tumors.

Authors:  K H Plate; H D Mennel
Journal:  Exp Toxicol Pathol       Date:  1995-05

9.  Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

Authors:  Benjamin M Ellingson; Hyun J Kim; Davis C Woodworth; Whitney B Pope; Jonathan N Cloughesy; Robert J Harris; Albert Lai; Phioanh L Nghiemphu; Timothy F Cloughesy
Journal:  Radiology       Date:  2013-11-27       Impact factor: 11.105

10.  The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo.

Authors:  L Griffiths; G U Dachs; R Bicknell; A L Harris; I J Stratford
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

View more
  8 in total

1.  High-sensitivity CEST mapping using a spatiotemporal correlation-enhanced method.

Authors:  Lin Chen; Suyi Cao; Raymond C Koehler; Peter C M van Zijl; Jiadi Xu
Journal:  Magn Reson Med       Date:  2020-06-29       Impact factor: 4.668

2.  Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

Authors:  Hiroyuki Tatekawa; Akifumi Hagiwara; Hiroyuki Uetani; Jingwen Yao; Talia C Oughourlian; Shadfar Bahri; Chencai Wang; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2020-09-14       Impact factor: 4.130

Review 3.  Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Timothy F Cloughesy
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

Review 4.  Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.

Authors:  Jianpan Huang; Zilin Chen; Se-Weon Park; Joseph H C Lai; Kannie W Y Chan
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

5.  Regional 18F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma.

Authors:  Jianhua Qin; Yu Tang; Bao Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

6.  Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging.

Authors:  Hamed Akbari; Anahita Fathi Kazerooni; Jeffrey B Ware; Elizabeth Mamourian; Hannah Anderson; Samantha Guiry; Chiharu Sako; Catalina Raymond; Jingwen Yao; Steven Brem; Donald M O'Rourke; Arati S Desai; Stephen J Bagley; Benjamin M Ellingson; Christos Davatzikos; Ali Nabavizadeh
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

7.  Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas.

Authors:  Talia C Oughourlian; Jingwen Yao; Akifumi Hagiwara; David A Nathanson; Catalina Raymond; Whitney B Pope; Noriko Salamon; Albert Lai; Matthew Ji; Phioanh L Nghiemphu; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Neuroradiology       Date:  2020-10-26       Impact factor: 2.995

Review 8.  Targeting Immunometabolism in Glioblastoma.

Authors:  Aditya A Mohan; William H Tomaszewski; Aden P Haskell-Mendoza; Kelly M Hotchkiss; Kirit Singh; Jessica L Reedy; Peter E Fecci; John H Sampson; Mustafa Khasraw
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.